Emerging Techniques for Cardiovascular PET

Overview

Journal Cardiovasc Innov Appl

Date 2021 Sep 23

PMID 34552704

Citations 4

Authors

Austin A Robinson

Jamieson M Bourque

Affiliations

Soon will be listed here.

Abstract

The application of positron emission tomography (PET) to cardiac disease has yielded tremendous developments in the evaluation of coronary artery, myocardial, and valvular heart disease over the past several decades. These advances have included development of new radiotracers, incremental technological improvements, and coupling of PET with other non-invasive cardiac imaging modalities. The current era has seen rapid, successive and wide-ranging advances in PET myocardial perfusion and metabolic imaging. This review will address emerging techniques in cardiovascular PET imaging, including the measurement of absolute myocardial blood flow (MBF), use of novel tracers, and other advances in heart failure, infection imaging, and valvular disease.

Citing Articles

The Effect of Antioxidant Polyphenol Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis.

Wan S, Luo J, Zhu Y, An P, Luo Y, Xing Q Nutrients. 2024; 16(23).

PMID: 39683599 PMC: 11644654. DOI: 10.3390/nu16234206.

Innovations in Imaging: F-Fluorodeoxyglucose PET/CT for Assessment of Cardiovascular Infection and Inflammation.

Trivedi S, Bourque J Curr Cardiol Rep. 2024; 26(12):1413-1425.

PMID: 39316219 PMC: 11668860. DOI: 10.1007/s11886-024-02137-z.

Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with AlF/Ga/In.

Sihver W, Walther M, Ullrich M, Nitt-Weber A, Bohme J, Reissig F Bioconjug Chem. 2024; 35(9):1402-1416.

PMID: 39185789 PMC: 11417994. DOI: 10.1021/acs.bioconjchem.4c00313.

Reaction of [F]Fluoride at Heteroatoms and Metals for Imaging of Peptides and Proteins by Positron Emission Tomography.

Scroggie K, Perkins M, Chalker J Front Chem. 2021; 9:687678.

PMID: 34249861 PMC: 8262615. DOI: 10.3389/fchem.2021.687678.

References

Schwaiger M, Kalff V, Rosenspire K, Haka M, Molina E, Hutchins G . Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990; 82(2):457-64. DOI: 10.1161/01.cir.82.2.457. View

Kusumoto F, Schoenfeld M, Wilkoff B, Berul C, Birgersdotter-Green U, Carrillo R . 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017; 14(12):e503-e551. DOI: 10.1016/j.hrthm.2017.09.001. View

Luisi Jr A, Suzuki G, DeKemp R, Haka M, Toorongian S, Canty Jr J . Regional 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med. 2005; 46(8):1368-74. View

Nensa F, Poeppel T, Krings P, Schlosser T . Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging. Eur Heart J. 2014; 35(32):2173. DOI: 10.1093/eurheartj/ehu086. View

Nensa F, Bamberg F, Rischpler C, Menezes L, Poeppel T, Fougere C . Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM). Eur Radiol. 2018; 28(10):4086-4101. PMC: 6132726. DOI: 10.1007/s00330-017-5008-4. View

Sogbein O, Pelletier-Galarneau M, Schindler T, Wei L, Wells R, Ruddy T . New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed Res Int. 2014; 2014:942960. PMC: 4034657. DOI: 10.1155/2014/942960. View

Kim Y, Ha S, Kim Y . Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis. J Nucl Cardiol. 2018; 27(1):123-132. DOI: 10.1007/s12350-018-1365-x. View

Rudd J, Warburton E, Fryer T, Jones H, Clark J, Antoun N . Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002; 105(23):2708-11. DOI: 10.1161/01.cir.0000020548.60110.76. View

Joshi N, Vesey A, Williams M, Shah A, Calvert P, Craighead F . 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2013; 383(9918):705-13. DOI: 10.1016/S0140-6736(13)61754-7. View

10.

Rizvi A, Han D, Danad I, Hartaigh B, Lee J, Gransar H . Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography: A Meta-Analysis. JACC Cardiovasc Imaging. 2017; 11(4):589-599. PMC: 5808913. DOI: 10.1016/j.jcmg.2017.05.020. View

11.

Pollack A, Nazif T, Mancini D, Weisz G . Detection and imaging of cardiac allograft vasculopathy. JACC Cardiovasc Imaging. 2013; 6(5):613-23. DOI: 10.1016/j.jcmg.2013.03.001. View

12.

Nekolla S, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A . Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009; 119(17):2333-42. DOI: 10.1161/CIRCULATIONAHA.108.797761. View

13.

Chih S, Chong A, Erthal F, deKemp R, Davies R, Stadnick E . PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy. J Am Coll Cardiol. 2018; 71(13):1444-1456. DOI: 10.1016/j.jacc.2018.01.062. View

14.

Herzog B, Husmann L, Valenta I, Gaemperli O, Siegrist P, Tay F . Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009; 54(2):150-6. DOI: 10.1016/j.jacc.2009.02.069. View

15.

Mc Ardle B, Birnie D, Klein R, de Kemp R, Leung E, Renaud J . Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?. Circ Cardiovasc Imaging. 2013; 6(5):617-26. DOI: 10.1161/CIRCIMAGING.112.000289. View

16.

Tarkin J, Joshi F, Evans N, Chowdhury M, Figg N, Shah A . Detection of Atherosclerotic Inflammation by Ga-DOTATATE PET Compared to [F]FDG PET Imaging. J Am Coll Cardiol. 2017; 69(14):1774-1791. PMC: 5381358. DOI: 10.1016/j.jacc.2017.01.060. View

17.

Soussan M, Brillet P, Nunes H, Pop G, Ouvrier M, Naggara N . Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2012; 20(1):120-7. DOI: 10.1007/s12350-012-9653-3. View

18.

Fallavollita J, Heavey B, Luisi Jr A, Michalek S, Baldwa S, Mashtare Jr T . Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2013; 63(2):141-9. PMC: 3954563. DOI: 10.1016/j.jacc.2013.07.096. View

19.

Murthy V, Bateman T, Beanlands R, Berman D, Borges-Neto S, Chareonthaitawee P . Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2017; 25(1):269-297. DOI: 10.1007/s12350-017-1110-x. View

20.

Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt M, Blankstein R . Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016; 6(1):50-63. PMC: 4731586. DOI: 10.3978/j.issn.2223-3652.2015.12.13. View